ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 84.20
+2.50 (3.06%)
Aug 12, 2025, 1:59 PM CST
The Duckhorn Portfolio Market Cap
ACRO Biomedical has a market cap or net worth of 5.19 billion as of August 11, 2025. Its market cap has increased by 221.21% in one year.
Market Cap
5.19B
Enterprise Value
4.71B
Revenue
44.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
$84.20
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 5.19B, an increase of 276.15%. That is a compound annual growth rate of 38.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.19B | 231.90% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |